Optivia Press Releases
FREE ROAD MAP TO FDA WHITE-PAPER
The ITC Transporter White Paper provides detailed guidance for transporter mediated DDI studies for the seven transporters recommended in the March 17, 2010 FDA Advisory Committee vote. Get the White Paper and a Road Map Summary to help navigate it.
QUESTIONS?
Speak with one of our transporter specialists about your needs to understand how we can help you and the results you can expect.
CONTACT US:
888-OPTIVIA (888-678-4842)
Optivia Press Releases
May 17, 2011
Former Pharma Executive, Dr. Dominique Bridon, Joins Optivia Senior Management Optivia announces the appointment of Dominique Bridon, Ph.D. as Executive Vice President and Chief Operating Officer.
Read More......
April 5, 2011
Optivia Awarded $1.85 Million SBIR Grant to Build Comprehensive Platform for Assessing Dangerous Drug-Drug Interactions Joint Research with UCSF Will Also Profile 2,000 Prescription Drugs for Potential DDIs
Read More......
February 1, 2011
Optivia Signs Agreement With U.S. FDA To Assess Role Of Dietary Supplements In Drug-Induced Liver Injury Research Will Evaluate Effect of Dietary Supplements on Key Drug Transporters
Read More......
November 16, 2010
Optivia and UCSF Collaborate to Predict Liver Toxicity of Drugs in Development
Read More......
November 15, 2010
Optivia Biotechnology Names Dr. Yuichi Sugiyama to Scientific Advisory Board
Read More......
May 11, 2010
Optivia Launches Comprehensive Assay Panel for Assessing Transporter-Related Drug-Drug Interactions and Improving Drug Safety: OptiDDI™ Suite Meets New FDA Advisory Committee and International Transporter Consortium Recommendations
Read More......